Disease Mongering: A Psychological Move Towards An Illness | 101461
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 2384

Journal of Addiction Research & Therapy received 2384 citations as per google scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Disease mongering: A psychological move towards an illness

9th International Conference on Addiction & Psychiatry

Sadia Shakeel

Dow University of Health Sciences, Pakistan

ScientificTracks Abstracts: J Addict Res Ther

DOI: 10.4172/2155-6105-C3-042

Disease mongering is the selling of sickness that widens the boundaries of illness in order to grow markets for those who sell and deliver treatments. It is a process that turns healthy people into patients, causes iatrogenic harm, and wastes precious resources. Disease mongering is the contemporary form of ???medicalisation.??? It is a process now driven by both corporate and professional interests, and it has become part of the global debate about health care. International consumer groups now target drug company???backed disease mongering as a wasteful threat to public health, while the global pharmaceutical industry has been forced to defend its promotion of ???lifestyle??? medicines for problems like slimming and sexual difficulties. Pharmaceutical firms are inventing diseases to sell more drugs, researchers have warned. "It is exemplified mostly explicitly by many pharmaceutical industry-funded disease awareness campaigns - more often designed to sell drugs than to illuminate or to inform or educate about the prevention of illness or the maintenance of health. Disease-mongering promotes non-existent diseases and exaggerates mild problems to boost profits. A key strategy of the alliances is to target the news media with stories designed to create fears about the condition or disease and draw attention to the latest treatment.

Sadia Shakeel obtained her M.Pharm (Pharmaceutics) in 2009 from University of Karachi, Pakistan and awarded doctorate degree in Pharmacy practice in 2017 from Jinnah University for women, Pakistan. She is a Clinical Research Certified Professional from Dow University of Health Sciences. She is currently rendering her services as a Faculty member in Dow College of Pharmacy, Dow University of Health Sciences, one of the oldest public research university located in urban metropolitan area of Karachi, Pakistan. She is a prolific researcher and author. She has authored over 70 peer-reviewed publications in international journals and several research abstracts / research posters to her credit.

E-mail: [email protected]